ITGAX and melanoma: Laser-capture-microdissection of tumor tissues followed by RT-PCR analysis suggested that in vivo NLGP treatment showed no change in melanoma (gp100) and dendritic cell (DC) (CD11c) marker, but an increase in macrophage marker (CD11b) (Figure 1C).